Humana 2027 increased by 21.7% to $28.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 36.4%, from $44.00M to $28.00M. This increase may warrant attention — for this metric, lower values are generally preferred.
Higher expenses reduce reported net income, though they are non-cash in nature and do not impact immediate liquidity.
This represents the periodic expense recognized in the income statement to allocate the cost of finite-lived intangible...
Standard non-cash expense item for companies with significant intangible asset bases.
other_finite_lived_intangible_assets_amortization_expens_a31c97| Q1 '23 | Q2 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|
| Value | $56.00M | $60.00M | $58.00M | $58.00M | $58.00M | $44.00M | $44.00M | $23.00M | $28.00M |
| QoQ Change | — | +7.1% | -3.3% | +0.0% | +0.0% | -24.1% | +0.0% | -47.7% | +21.7% |
| YoY Change | — | — | +3.6% | -3.3% | — | -24.1% | -24.1% | -60.3% | -36.4% |